CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial 期刊论文
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 卷号: 73, 期号: 4
作者:  Szarek, Michael;  White, Harvey D.;  Schwartz, Gregory G.;  Alings, Marco;  Bhatt, Deepak L.
收藏  |  浏览/下载：131/0  |  提交时间：2019/12/05
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial 期刊论文
2019, 卷号: 157, 期号: 2, 页码: 403-+
作者:  Moayyedi, Paul;  Eikelboom, John W.;  Bosch, Jackie;  Connolly, Stuart J.;  Dyal, Leanne
收藏  |  浏览/下载：41/0  |  提交时间：2020/01/03
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin 期刊论文
2019, 卷号: 157, 期号: 3, 页码: 682-+
作者:  Moayyedi, Paul;  Eikelboom, John W.;  Bosch, Jackie;  Connolly, Stuart J.;  Dyal, Leanne
收藏  |  浏览/下载：36/0  |  提交时间：2020/01/03
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial 期刊论文
2019, 卷号: 4, 期号: 3, 页码: 273-286
作者:  Hochman, Judith S.;  Reynolds, Harmony R.;  Bangalore, Sripal;  O'Brien, Sean M.;  Alexander, Karen P.
收藏  |  浏览/下载：53/0  |  提交时间：2020/01/03
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 期刊论文
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 卷号: 379, 期号: 22, 页码: 2097-2107
作者:  Schwartz, G. G.;  Steg, P. G.;  Szarek, M.;  Bhatt, D. L.;  Bittner, V. A.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial 期刊论文
2017, 卷号: 33, 期号: 8, 页码: 1027-1035
作者:  Bosch, Jackie;  Eikelboom, John W.;  Connolly, Stuart J.;  Bruns, Nancy Cook;  Lanius, Vivian
收藏  |  浏览/下载：40/0  |  提交时间：2020/01/04
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease 期刊论文
2017, 卷号: 377, 期号: 14, 页码: 1319-1330
作者:  Eikelboom, J. W.;  Connolly, S. J.;  Bosch, J.;  Dagenais, G. R.;  Hart, R. G.
收藏  |  浏览/下载：58/0  |  提交时间：2020/01/03
Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease 期刊论文
Journal of the American Heart Association, 2016, 卷号: 5, 期号: 6
作者:  Wallentin, Lars C./7102987659[0];  Held, Claes/7005675618[1];  Armstrong, Paul W./35380325200[2];  Cannon, Christopher Paul/7202171576[3];  Davies, Richard Y./7404392804[4]
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
Long-term use of ticagrelor in patients with prior myocardial infarction. 期刊论文
The New England journal of medicine, 2015, 卷号: 372, 期号: 19, 页码: 1791-1800
作者:  Bonaca, Marc P.*;  Bhatt, Deepak L.;  Cohen, Marc;  Steg, Philippe Gabriel;  Storey, Robert F.
收藏  |  浏览/下载：58/0  |  提交时间：2019/12/03
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease 期刊论文
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 卷号: 370, 期号: 18
作者:  White, Harvey D.;  Held, Claes;  Stewart, Ralph;  Tarka, Elizabeth;  Brown, Rebekkah
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace